Receptor Protein-Tyrosine Kinases
- Name
- Receptor Protein-Tyrosine Kinases
- Accession Number
- DBCAT002977
- Description
A class of cellular receptors that have an intrinsic PROTEIN-TYROSINE KINASE activity.
- Drugs
Drug Drug Description Nelipepimut-S Investigated for use/treatment in prostate cancer and breast cancer. VEGFR2-169 VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)). - Drugs & Drug Targets
Drug Target Type Nelipepimut-S HLA class I histocompatibility antigen, A-2 alpha chain target Nelipepimut-S HLA class I histocompatibility antigen, A-3 alpha chain target